Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XOMA 052 in Type 1 Diabetes
NCT00998699Phase 2Completed
- Sponsor
- XOMA
- Start
- Feb 2010
- Primary completion
- Aug 2013
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of gevokizumab in type 1 diabetes mellitus (T1D), sponsored by XOMA. Started Feb 2010; status: completed.
02
Drugs
gevokizumab
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00998699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00998699.